Abbvie reported $2.98B in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbott ABT:US $ 2.74B 14M
Abbvie ABBV:US $ 2.98B 99M
Acceleron Pharma XLRN:US $ 45.11M 9.64M
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
ALKERMES ALKS:US 136.21M 2.97M
Amgen AMGN:US $ 1.31B 79M
Astrazeneca AZN:US 2.99B 412M
AstraZeneca AZN:LN 2.99B 412M
Biogen BIIB:US $ 654.1M 16.8M
Biomarin Pharmaceutical BMRN:US $ 183.33M 828K
Bristol Myers Squibb BMY:US $ 1.79B 95M
Chemocentryx CCXI:US $ 19.6M 100K
Coherus Biosciences CHRS:US $ 39.92M 420K
Eisai 4523:JP 79.76B 5.03B
Eli Lilly And LLY:US $ 1.58B 107.8M
Endo International Ordinary Shares ENDP:US 241.92M 70.98M
Gilead Sciences GILD:US $ 1.18B 173M
GlaxoSmithKline GSK:LN 2.5B 6M
Horizon Pharma HZNP:US 360.26M 5.06M
Infinity Pharmaceuticals INFI:US 3.85M 349K
Intercept Pharmaceuticals ICPT:US $ 53.34M 4.32M
JAZZ PHA JAZZ:US 363.68M 65.35M
Johnson & Johnson JNJ:US $ 6B 73M
Merk MRK:US $ 2.27B 9M
Neurocrine Biosciences NBIX:US $ 154.6M 11.4M
Novartis NOVN:VX 3.6B 109M
Pacira Pharmaceuticals PCRX:US $ 48.81M 2.01M
Perrigo Ordinary Shares PRGO:US 283.6M 11.7M
Pfizer PFE:US $ 2.73B 61M
Regeneron Pharmaceuticals REGN:US $ 445M 30.3M
Revance Therapeutics RVNC:US $ 51.12M 2.11M
Teva Pharmaceutical Industries TEVA:US 864M 32M
Ultragenyx Pharmaceutical RARE:US $ 53.88M 473K
United Therapeutics UTHR:US $ 109.1M 3.7M
Vertex Pharmaceuticals VRTX:US $ 198.19M 3.52M
Zoetis ZTS:US $ 504M 9M